Evidence-Based Complementary and Alternative Medicine / 2022 / Article / Tab 3 / Research Article
A Network Meta-Analysis of the Clinical Efficacy and Safety of Commonly Used Chinese Patent Medicines in the Auxiliary Treatment of Poststroke Depression Table 3 Ranking list of different interventions.
Intervention measures Clinical effective rate HAMD score NIHSS score TESS score Wuling capsule 0.10 0.00 0.00 0.00 Xiaoyao pill 0.14 0.00 0.14 — Danzhi Xiaoyao pill 0.07 0.00 0.05 — Chaihu Shugan powder 0.25 0.05 — 0.39 Shugan Jieyu capsule 0.06 0.00 0.01 0.01 Jieyu Anshen capsule 0.39 0.06 — — Yangxue Qingnao granule 0.00 0.00 0.04 0.02 Blank control 0.00 0.88 0.75 0.58
